Medical News

RSS

Combined behavioral interventions most effective way to reduce heart disease risk

Combining counseling, extended follow-up with a healthcare provider and self-monitoring of diet and exercise is the most effective way to help patients embrace lifestyle changes that can lower their risk for heart and blood vessel (cardiovascular) diseases, according to a scientific statement published in Circulation: Journal of the American Heart Association.

13 Jul 2010

Stereotaxis reports new capital orders of $10.2M in second-quarter 2010

Stereotaxis, Inc. announced today that its new capital order momentum continued to build in the second quarter of 2010. The Company generated new capital orders of $10.2 million, more than doubling new capital orders from the 2009 second quarter and representing a 42% sequential increase over orders in the first quarter of 2010. New orders from North America totaled $5.1 million of the total orders in the quarter.

13 Jul 2010

Cognis exclusively licensed two new active ingredients from IMD

Specialty chemicals supplier Cognis and InterMed Discovery, a world class natural product lead-discovery company, are continuing their strategic cooperation: Cognis has now exclusively licensed two new active ingredients for weight management and cognitive performance from IMD, further expanding the company's innovation pipeline.

13 Jul 2010

Stanford Hospital and Clinics completes migration to InterSystems Ensemble platform

InterSystems Corporation today highlighted the successful completion of an enterprise-scale integration initiative at Stanford Hospital and Clinics (SHC). With the migration from legacy integration software to the InterSystems Ensemble® rapid integration and development platform, SHC is now processing more than 2.2 million HL7 messaging transactions on a daily basis.

13 Jul 2010

Lanx launches Lumbar Motion Monitor Commercialization project in Ohio

Colorado biomedical company, Lanx Inc., has chosen Ohio as the location to launch its Lumbar Motion Monitor Commercialization project. The company, which chose Ohio over other Midwest states, said the state's biomedical industry and support from programs like Ohio Third Frontier were key to the decision.

13 Jul 2010

KCI announces creation of Advanced Research and Technology center

Kinetic Concepts, Inc. announced today the creation of an Advanced Research and Technology (ART) center that will lead the company's efforts to develop revolutionary new wound healing, regenerative medicine, and therapeutic support system technologies and treatments.

13 Jul 2010

Hi-Tech Pharmacal fourth-quarter net sales increase 6% to $40.5 million

Hi-Tech Pharmacal Co., Inc. today reported results for the fourth quarter and year ended April 30, 2010.

13 Jul 2010

Transcend Services enters into a 27 month contract with HealthTrust

TRANSCEND SERVICES, INC. announced today that it has entered into a 27 month contract with HealthTrust Purchasing Group, LP to offer medical transcription and clinical documentation products and services to nearly 1,400 not-for-profit and for-profit acute care facilities and other health-care organizations within the HealthTrust membership.

13 Jul 2010

Wyse Technology announces partnership, continued success with LLS

Wyse Technology, the inventor and global leader in cloud client computing, today announced its partnership and continued success with The Leukemia and Lymphoma Society, the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services.

13 Jul 2010

Researchers use topological optimization to design facial bone replacements

Scientists are using the engineering technology behind the creation of high-performance aircraft components to design 3-D models for the replacement of delicate and complex facial bones lost to cancer surgery or trauma.

13 Jul 2010

Community-based interventions for childhood obesity differ depending on age group, expert says

Community-based interventions designed to prevent obesity in children seem to work best in those under the age of five, while there is evidence of some success in primary school children, but very mixed effects in adolescents, a leading expert in the field said today (Tuesday).

13 Jul 2010

Protalix BioTherapeutics' taliglucerase alfa for Gaucher disease granted French ATU

Protalix BioTherapeutics, Inc. announced today that the French regulatory authority has granted an Autorisation Temporaire d'Utilisation (ATU), or Temporary Authorization for Use, for taliglucerase alfa for the treatment of Gaucher disease. An ATU is the regulatory mechanism used by the French Health Products and Safety Agency to make non-approved drugs available to patients in France when a genuine public health need exists.

13 Jul 2010

SeqWright congratulates EraGen on successful FDA 510(k) market clearance of MultiCode-RTx HSV 1 & 2 Kit

EraGen Biosciences Inc., Madison, Wis., was congratulated today by SeqWright, Inc., Houston, on EraGen's successful FDA 510(k) market clearance of its MultiCode-RTx HSV 1 & 2 Kit. This new kit is the first FDA-cleared PCR-based qualitative in vitro diagnostic test for the detection and typing of HSV-1 and HSV-2 from vaginal lesion swab specimens in symptomatic female patients.

13 Jul 2010

Brains of overweight people are less sensitive to feelings of hunger, finds new research

Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior, the foremost society for research into all aspects of eating and drinking behavior, finds that that feelings of hunger have less influence on how the brain responds to the smell and taste of food in overweight than healthy weight individuals.

13 Jul 2010

Astra Tech expands Atlantis patient-specific abutment options

Astra Tech expands the Atlantis patient-specific abutment options to include Dentsply Friadent's XiVE and Frialit implants and Straumann's Standard/Standard Plus (Wide Neck) implants for North American customers.

13 Jul 2010

Philippine FDA's LSD attains ISO/IEC 17025:2005 accreditation for testing and calibration laboratories

In an effort that will contribute to raising the quality of medicines in the Philippines and surrounding regions, the Laboratory Services Division (LSD) of the Philippine Food and Drug Administration (FDA) has attained the internationally recognized accreditation for testing and calibration laboratories, International Organization for Standardization/ International Electrotechnical Commission (ISO/IEC) 17025:2005.

13 Jul 2010

BioImage Study published in American Heart Journal

BG Medicine, Inc., a U.S.-based biomarker discovery and in vitro diagnostics company, announced today the publication of The BioImage Study trial design and key objectives in the American Heart Journal. The American Heart Journal is a peer- reviewed journal that publishes original research and review articles on clinical research studies in the field of cardiology.

13 Jul 2010

Cepheid denies Abaxis' allegations of patent infringement, files answer and counterclaims

Cepheid announced today that it has filed an answer and counterclaims in a patent suit brought by Abaxis on June 28, 2010 in the United States District Court for the Northern District of California. In its filing, Cepheid denied Abaxis' allegations of patent infringement, asked the Court to determine it has paid all royalties due and is in full compliance with all the terms of its license, and to find that Abaxis' patents are invalid.

13 Jul 2010

MAP Pharmaceuticals reports results from LEVADEX PK and safety clinical trial in smokers, non-smokers

MAP Pharmaceuticals, Inc. today announced results from a clinical trial comparing the pharmacokinetics (PK) and safety of LEVADEX™ orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. The trial was designed to measure whether systemic absorption and exposure in smokers is greater than in non-smokers. In the trial, the systemic absorption of LEVADEX was not higher and systemic exposure to DHE was not greater in smokers than in non-smokers.

13 Jul 2010

RXi Pharmaceuticals receives SBIR grant to further develop novel RNAi therapeutics

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced that it was awarded an Advanced Technology Small Business Innovation Research grant by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

13 Jul 2010

Medical News

Combined behavioral interventions most effective way to reduce heart disease risk

Stereotaxis reports new capital orders of $10.2M in second-quarter 2010

Cognis exclusively licensed two new active ingredients from IMD

Stanford Hospital and Clinics completes migration to InterSystems Ensemble platform

Lanx launches Lumbar Motion Monitor Commercialization project in Ohio

KCI announces creation of Advanced Research and Technology center

Hi-Tech Pharmacal fourth-quarter net sales increase 6% to $40.5 million

Transcend Services enters into a 27 month contract with HealthTrust

Wyse Technology announces partnership, continued success with LLS

Researchers use topological optimization to design facial bone replacements

Community-based interventions for childhood obesity differ depending on age group, expert says

Protalix BioTherapeutics' taliglucerase alfa for Gaucher disease granted French ATU

SeqWright congratulates EraGen on successful FDA 510(k) market clearance of MultiCode-RTx HSV 1 & 2 Kit

Brains of overweight people are less sensitive to feelings of hunger, finds new research

Astra Tech expands Atlantis patient-specific abutment options

Philippine FDA's LSD attains ISO/IEC 17025:2005 accreditation for testing and calibration laboratories

BioImage Study published in American Heart Journal

Cepheid denies Abaxis' allegations of patent infringement, files answer and counterclaims

MAP Pharmaceuticals reports results from LEVADEX PK and safety clinical trial in smokers, non-smokers

RXi Pharmaceuticals receives SBIR grant to further develop novel RNAi therapeutics

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News